血清钾与透析液钾浓度和初始血液透析的老年美国人群新发房颤的关联:一项队列研究
该队列研究纳入2006至2011年间开始血液透析且既往无房颤诊断的15190名美国老年人,评估血清钾和透析液钾浓度与新发房颤的关联。随访21907人年期间2869人发生房颤,低血清钾与房颤风险升高相关,而透析液钾3 mEq/l相比2 mEq/l与新发房颤发生率降低14%独立相关。
要点
- 血清钾与房颤风险呈J形关联,低于4.5 mEq/l时风险升高,高于4.5 mEq/l时无关联。
- 透析液钾3 mEq/l相比2 mEq/l与新发房颤发生率降低14%(95%CI 5%-24%)独立相关。
- 血清钾与透析液钾之间未检测到效应修饰(P=0.34)。
核心结论
- 较低的血清钾与新发房颤独立相关,而升高的血清钾则无此关联。
- 研究结果支持采用透析液钾浓度为3 mEq/l的透析液,无论患者血清钾水平如何,并从实践中淘汰更低钾浓度的透析液。
- 需要将患者随机分配至不同透析液钾浓度的临床试验来确定因果关系。
研究设计与样本
- 队列研究,使用Medicare理赔数据与一家透析提供者的临床数据合并。
- 纳入标准为透析开始时年龄≥67岁、参加按服务付费的Medicare、且在透析第120天前无房颤诊断。
- 共纳入15190人,平均年龄76.3岁,随访时间为2006年至2011年。
- 血清钾和透析液钾按30天间隔评估,并在随后的30天间隔内随访房颤发生率。
主要发现
- 平均血清钾为4.5 mEq/l;透析液钾为3 mEq/l者占34%,为2 mEq/l者占52%。
- 随访21907人年期间,2869人发生新发房颤,发病率为每100人年13.1(95%CI 12.6-13.6)。
- 多变量校正后,血清钾与新发房颤的关联呈J形:相对于血清钾4.5 mEq/l,较低血清钾与房颤风险升高相关,而较高血清钾的置信带提示无关联。
- 透析液钾3 mEq/l相比2 mEq/l与新发房颤发生率降低14%(95%CI 5%-24%)独立相关。
- 未检测到血清钾与透析液钾之间的效应修饰(P=0.34)。
临床怎么用
- 研究结果支持采用透析液钾浓度为3 mEq/l的透析液,无论患者血清钾水平如何。
- 研究结果支持从实践中淘汰更低钾浓度的透析液。
- 作者认为需要将患者随机分配至不同透析液钾浓度的临床试验来确定因果关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Atrial fibrillation (AF) disproportionally affects persons on maintenance hemodialysis (HD). Associations of serum and dialysate potassium concentrations [K+] with AF incidence are poorly understood. METHODS: We conducted a cohort study using Medicare claims merged with clinical data from a dialysis provider to determine whether serum-[K+] and/or dialysate-[K+] independently associated with AF incidence. Persons insured by fee-for-service Medicare aged ≥67 years at dialysis initiation and free from diagnosed AF prior to day 120 of dialysis were eligible. Serum-[K+] and dialysate-[K+] were assessed in 30-day intervals and patients were followed-up with for AF incidence in subsequent 30-day intervals. RESULTS: During 2006 to 2011, 15,190 persons (mean age = 76.3 years) initiating HD had no prior AF diagnosis. Mean serum-[K+] was 4.5 mEq/l; dialysate-[K+] was 3 mEq/l in 34% and 2 mEq/l in 52% of patients. Followed-up over 21,907 person-years, 2869 persons had incident AF (incidence/100 person-years, 13.1 [95% confidence interval [CI], 12.6-13.6]). The multivariable-adjusted association of serum-[K+] with incident AF was J-shaped as follows: relative to a serum-[K+] of 4.5 mEq/l, lower serum-[K+] associated with increased AF risk, whereas confidence bands for higher serum-[K+] indicated no association. Dialysis against a dialysate-[K+] of 3 mEq/l versus 2 mEq/l independently associated with a 14% (95% CI, 5%-24%) lower incidence of AF. No effect modification between serum-[K+] and dialysate-[K+] was detected (P = 0.34). CONCLUSION: Lower serum-[K+] was independently associated with incident AF whereas elevated serum-[K+] was not. The findings support adoption of dialysate solutions with a dialysate-[K+] of 3 mEq/l, regardless of patients' serum-[K+], and elimination of lower dialysate-[K+] solutions from practice. Clinical trials randomizing patients to different dialysate-[K+] are warranted to establish causality.
引用
- Hu A, Liu S, Montez-Rath ME, et al. Associations of Serum and Dialysate Potassium Concentrations With Incident Atrial Fibrillation in a Cohort Study of Older US Persons Initiating Hemodialysis for Kidney Failure. Kidney Int Rep. 2022. PMID: 36815107. doi:10.1016/j.ekir.2022.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。